What is an IgG Avidity Test for Toxoplasmosis in Pregnancy?
At a Glance
An IgG avidity test for toxoplasmosis during pregnancy measures how strongly your antibodies bind to the parasite to estimate when you were infected. High avidity in the first trimester suggests an older infection with very low risk to the baby, while low avidity may indicate a recent infection.
An IgG avidity test is a specialized blood test used during pregnancy to help estimate exactly when you were infected with the Toxoplasma gondii parasite [1][2]. If a standard blood test shows you have toxoplasmosis antibodies, doctors use the avidity test to figure out if this is a brand new infection that happened during your pregnancy, or an old infection from months or years ago [1][3]. Distinguishing between a recent and past infection is crucial, because a recent infection during pregnancy carries a risk of being passed to your baby, while an older infection generally does not [4][5].
How the Avidity Test Works
When your body first fights off an infection, your immune system produces antibodies that are somewhat weak at grabbing onto the parasite. Over the course of several months, your immune system refines these antibodies, making them much better and stronger at binding to the invader [1][6].
Avidity simply refers to this binding strength—how tightly your antibodies hold onto the parasite [6]. By measuring this grip strength, the laboratory can estimate how long your body has been producing these antibodies.
What Your Results Mean
Your avidity test results will usually be categorized into one of three zones, which help guide your care:
- High Avidity: Your antibodies are binding very tightly to the parasite. This means the infection likely happened at least three to four months before the test was taken [7][8]. If you take this test early in your first trimester, a high avidity result is excellent news—it means you caught the infection before you got pregnant, and the risk to your baby is extremely low [3][7]. However, if you are tested later in your pregnancy (during your second or third trimester), a high avidity result means the infection could have happened three to four months ago—which might place the infection right at the beginning of your pregnancy [3]. In that case, your doctor will evaluate this result alongside other tests to understand your timeline.
- Low Avidity: Your antibodies are binding loosely. This suggests that the infection is recent, likely within the last few months [9]. While this means the infection may have occurred during your pregnancy and carries a higher risk, low avidity alone isn’t a perfect measure [9][10]. Some people continue to produce low-avidity antibodies for a long time, so doctors will always look at this result alongside other blood tests [10][11].
- Gray Zone or Borderline Avidity: Your results fall somewhere in the middle. These results are inconclusive, meaning it is unclear whether the infection is recent or from the past [8]. Because a recent infection cannot be definitively ruled out, your doctor will likely recommend repeating the blood test in three to four weeks to see if your antibody levels or avidity change [12][8].
What Happens Next?
Because interpreting these tests is complex, your blood sample is sent to a specialized clinical laboratory. Once the results return, your doctor will use them to determine the best next steps for you and your baby [2][13].
If your results show high avidity early in your first trimester, your doctor will usually offer reassurance, and you likely won’t need any special treatment or further invasive testing [7][3].
If your results show low or borderline avidity, your care team will monitor you more closely. They may:
- Prescribe medication: You may be started on an antibiotic like spiramycin. This medication is used to help prevent the parasite from crossing the placenta and reaching your baby [14][15]. If later testing confirms the baby has been infected, your medical team will likely switch your medication to a targeted therapy to treat the baby directly [14][15].
- Recommend an amniocentesis: To confirm whether the parasite has actually reached your baby, your doctor may suggest testing a small sample of your amniotic fluid [12][16]. This procedure is typically not performed immediately in early pregnancy; it is generally done after 18 weeks of pregnancy and at least four weeks after the suspected infection to ensure accurate results and safety [12][16].
- Run additional blood tests: Your doctor may combine the avidity test with other antibody tests (like IgM or IgA) to get a clearer picture of your infection timeline [11][13].
Common questions in this guide
What does a high avidity test result mean for toxoplasmosis?
What should I do if my toxoplasmosis avidity is low?
What happens if my avidity test is in the gray zone?
When is an amniocentesis done for suspected toxoplasmosis?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Based on my avidity results and when my blood was drawn, at what gestational age did my suspected infection likely occur?
- 2.Should I start a preventative medication like spiramycin right now, or should we wait for repeat blood tests?
- 3.If my results are in the gray zone, on what exact date should I return for my follow-up blood work?
- 4.At how many weeks of pregnancy would you recommend an amniocentesis for my specific situation?
- 5.If an amniocentesis eventually shows that the baby is infected, how will my medication regimen change?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (16)
- 1
Role of Toxoplasma gondii IgG Avidity Testing in Discriminating between Acute and Chronic Toxoplasmosis in Pregnancy.
Teimouri A, Mohtasebi S, Kazemirad E, Keshavarz H
Journal of clinical microbiology 2020; (58(9)) doi:10.1128/JCM.00505-20.
PMID: 32321784 - 2
Toxoplasma gondii-specific IgG avidity testing in pregnant women.
Garnaud C, Fricker-Hidalgo H, Evengård B, et al.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2020; (26(9)):1155-1160 doi:10.1016/j.cmi.2020.04.014.
PMID: 32334096 - 3
Serodiagnosis of Toxoplasmosis: The effect of measurement of IgG avidity in pregnant women in Rabat in Morocco.
Laboudi M, Sadak A
Acta tropica 2017; (172()):139-142 doi:10.1016/j.actatropica.2017.04.008.
PMID: 28433574 - 4
Seroepidemiological study of toxoplasmosis in women referred to a pre-marriage counseling center in Alborz Province, Iran.
Shahighi M, Heidari A, Keshavarz H, et al.
BMC research notes 2021; (14(1)):163 doi:10.1186/s13104-021-05581-0.
PMID: 33931121 - 5
Diagnosis of Acute Toxoplasmosis by IgG and IgM Antibodies and IgG Avidity in Pregnant Women from Mashhad, Eastern Iran.
Sharifi K, Hosseini Farash BR, Tara F, et al.
Iranian journal of parasitology 2019; (14(4)):639-645.
PMID: 32099567 - 6
Identification, production and assessment of two Toxoplasma gondii recombinant proteins for use in a Toxoplasma IgG avidity assay.
Teh AY, Amerizadeh A, Osman S, et al.
Pathogens and global health 2016; (110(7-8)):277-286 doi:10.1080/20477724.2016.1238186.
PMID: 27697019 - 7
Diagnostic accuracy of adjusted low IgG avidity index to predict acute Toxoplasma gondii infection in the first trimester of pregnancy.
Skvarc M
Folia parasitologica 2022; (69()).
PMID: 36314892 - 8
Comparison of Toxoplasma gondii IgG avidity Architect and Vidas assays with the estimated date of infection in pregnant women.
Smets A, Fauchier T, Michel G, et al.
Parasite (Paris, France) 2016; (23()):45 doi:10.1051/parasite/2016056.
PMID: 27762213 - 9
Interpretation of very low avidity indices acquired with the Liaison XL Toxo IgG avidity assay in dating toxoplasmosis infection.
Boquel F, Monpierre L, Imbert S, et al.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2019; (38(2)):253-257 doi:10.1007/s10096-018-3421-5.
PMID: 30411219 - 10
Detection of acute Toxoplasma gondii infection in pregnant women by IgG avidity and PCR analysis.
Roozbehani M, Gharavi MJ, Moradi M, Razmjou E
Tropical biomedicine 2018; (35(4)):908-914.
PMID: 33601840 - 11
Assessment of simultaneous IgM, IgG avidity, and IgA testing in diagnosis of acute toxoplasmosis in pregnant women: a systematic review and meta-analysis study.
Tork M, Sadeghi M, Asgarian-Omran H, et al.
BMC pregnancy and childbirth 2025; (25(1)):537 doi:10.1186/s12884-025-07580-6.
PMID: 40329230 - 12
Persistent Low Toxoplasma IgG Avidity Is Common in Pregnancy: Experience from Antenatal Testing in Norway.
Findal G, Stray-Pedersen B, Holter EK, et al.
PloS one 2015; (10(12)):e0145519 doi:10.1371/journal.pone.0145519.
PMID: 26714282 - 13
Significance of the avidity test in IgM+/IgG+ patients infected with Toxoplasma gondii and cytomegalovirus and its relationship with demographic data.
Etiz P, Emre T, Çetiner S, Allahverdiyev AM
Diagnostic microbiology and infectious disease 2026; (114(2)):117126 doi:10.1016/j.diagmicrobio.2025.117126.
PMID: 41046815 - 14
Congenital toxoplasmosis: Clinical features, outcomes, treatment, and prevention.
Singh S
Tropical parasitology 2016; (6(2)):113-122 doi:10.4103/2229-5070.190813.
PMID: 27722099 - 15
A fresh look at the role of spiramycin in preventing a neglected disease: meta-analyses of observational studies.
Montoya JG, Laessig K, Fazeli MS, et al.
European journal of medical research 2021; (26(1)):143 doi:10.1186/s40001-021-00606-7.
PMID: 34895348 - 16
IgG avidity and placenta real-time PCR in detection of active maternal toxoplasmosis: relation to pregnancy outcomes.
Allam AF, Shehab AY, Ahmed NA, et al.
Experimental parasitology 2025; (279()):109065 doi:10.1016/j.exppara.2025.109065.
PMID: 41260562
This page explains the toxoplasmosis IgG avidity test for educational purposes. Your obstetrician or maternal-fetal medicine specialist is the best source for interpreting your specific laboratory results and pregnancy timeline.
Get notified when new evidence is published on Congenital toxoplasmosis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.